Capital Group Investment Management Pte. Ltd. Novo Cure LTD Transaction History

Capital Group Investment Management Pte. Ltd.

$475 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $163,657 - $335,155	-4,062 Reduced 18.25%	18,199 $755,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $4,345 - $9,148	-77 Reduced 0.34%	22,261 $1.34 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $1.43 Million - $1.91 Million	22,338 New	22,338 $0

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

76.9M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$318 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$310 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$207 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$113 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$79.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.75B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.

Account